查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771616

美國冷凍消融探針市場規模、佔有率、應用趨勢分析、最終用途、細分市場預測，2025-2033

U.S. Cryoablation Probes Market Size, Share & Trends Analysis By Application (Cardiac Arrhythmias, Oncology, Dermatology), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers (ASCs)), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國冷凍消融探針市場摘要

美國冷凍消融探針市場規模預計在 2024 年為 5,171 萬美元，預計到 2033 年將達到 1.3316 億美元，2025 年至 2033 年的複合年成長率為 11.16%。由於幾個關鍵因素，包括需要微創治療的心血管和腫瘤疾病的盛行率不斷上升，該市場正在經歷顯著成長。

心血管疾病、肺癌、攝護腺癌、肝癌和腎癌等以心房顫動等心律不整為中心的慢性疾病的發生率日益上升，推動了對冷凍消融等微創治療方案的需求。例如，根據美國心臟協會的數據，目前約有500萬美國患有心房顫動（AFib），這是最常見的心律不整類型，但預計到2030年，這一數字將增至1,200萬以上。

此外，根據2025年2月發表的一篇研究論文和美國心臟協會的報告，2022年，美國成年人高血壓盛行率最高的州是密西西比州，為40.2%，最低的是科羅拉多，為24.6%。高血壓盛行率呈現隨年齡增加而上升趨勢，20至44歲族群的盛行率達28.5%，45至64歲族群的盛行率達58.6%，65歲以上族群的盛行率達76.5%。因此，高血壓盛行率的上升進一步推動了市場的成長。

此外，癌症盛行率的上升也有望在預測期內刺激需求。例如，根據美國癌症協會 (美國 Cancer Society) 的報告，預計到 2025 年，美國女性將新增約 316,950 例侵襲性乳癌病例，男性將新增約 2,800 例侵襲性乳癌病例。此外，預計女性將新增 59,080 例乳管原位癌 (DCIS)。預計約有 42,680 例乳癌相關死亡病例，其中女性 42,170 例，男性 510 例。

醫療技術的進步帶來了更精準、更有效的冷凍消融設備，這些設備正被醫療保健專業人員廣泛採用。老年人口的成長和對標靶腫瘤治療的偏好進一步推動了市場需求。此外，監管機構的核准以及主要企業之間的策略聯盟也促進了市場擴張。心臟病學、皮膚病學和疼痛管理領域應用的不斷成長，也促進了市場的成長。此外，人們對微創手術的認知和接受度不斷提高，加上其恢復時間更快、併發症更少等優勢，也刺激了市場擴張。老年人口的成長，使他們更容易罹患癌症和其他可透過冷凍消融治療的疾病，這進一步推動了市場需求。此外，醫療基礎設施投資的活性化以及旨在改善冷凍消融技術的研究活動也促進了市場的上升趨勢。總體而言，這些因素共同推動了冷凍消融探針的普及，為未來幾年市場持續成長奠定了基礎。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國冷凍消融探針市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國冷凍消融探針市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國冷凍消融探針市場：應用評估與趨勢分析

  • 細分儀表板
  • 美國冷凍消融探針市場波動分析
  • 美國冷凍消融探針市場規模及應用趨勢分析（2021-2033）
  • 心律不整
  • 腫瘤學
  • 皮膚科
  • 其他

5. 冷凍消融探針設備－最終用途估計與趨勢分析

  • 細分儀表板
  • 美國冷凍消融探針市場波動分析
  • 美國冷凍消融探針市場規模及趨勢分析（依最終用途）（2021-2033）
  • 醫院
    • 2021-2033年醫院市場估計與預測
  • 專科診所
    • 專科診所市場估計與預測 2021-2033
  • 門診手術中心（ASC）
    • 門診手術中心（ASC）市場估計與預測（2021-2033）
  • 其他
    • 2021-2033年其他市場估計與預測

第6章 競爭態勢

  • 市場參與企業分類
  • 主要企業簡介
    • Atricure, Inc.
    • Varian, A Siemens Healthineers Company
    • IceCure Medical
    • Medtronic
    • Bruker
    • Erbe USA, Incorporated
    • Keeler
    • HealthTronics, Inc.
  • 2024年公司市場佔有率分析
  • 其他主要市場公司名單
Product Code: GVR-4-68040-623-7

U.S. Cryoablation Probes Market Summary

The U.S. cryoablation probes market size was estimated at USD 51.71 million in 2024 and is projected to reach USD 133.16 million by 2033, growing at a CAGR of 11.16% from 2025 to 2033. The market is witnessing significant growth driven by several key factors. These include the increasing prevalence of cardiovascular and oncological diseases, which necessitate minimally invasive treatment options.

Increasing prevalence of chronic diseases, such as cardiovascular diseases, mainly cardiac arrhythmia, such as atrial fibrillation, cancer, particularly lung, prostate, liver, and kidney cancers, among others, has heightened demand for minimally invasive treatment options like cryoablation. For instance, according to the American Heart Association, Inc., currently, an estimated five million Americans are living with atrial fibrillation (AFib), which is the most common type of cardiac arrhythmia, and this number is expected to increase to over 12 million by 2030.

Furthermore, according to a research article published in February 2025 and an American Heart Association report, in 2022, the highest rate of high blood pressure among U.S. adults was observed in Mississippi at 40.2%, while Colorado had the lowest at 24.6%. Hypertension prevalence tends to rise with age, reaching 28.5% among individuals aged 20 to 44, 58.6% among those aged 45 to 64, and 76.5% in adults aged 65 and older. As a result, the growing prevalence of hypertension is further driving the market growth.

In addition, the growing prevalence of cancer is also expected to boost demand during the forecast period. For instance, according to the American Cancer Society report, in the U.S. in 2025, approximately 316,950 new cases of invasive breast cancer are expected to be diagnosed in women, along with approximately 2,800 cases in men. In addition, an estimated 59,080 cases of ductal carcinoma in situ (DCIS) will be diagnosed in women. The year is projected to see around 42,680 breast cancer-related deaths, with 42,170 occurring in women and 510 in men.

Advances in medical technology have led to the development of more precise and effective cryoablation devices, enhancing their adoption among healthcare providers. The expanding geriatric population and growing preference for targeted tumor therapies further boost demand. In addition, regulatory approvals and strategic collaborations among key players enhance market expansion. Increasing applications in cardiology, dermatology, and pain management contribute to market growth. In addition, growing awareness and acceptance of minimally invasive procedures, coupled with benefits such as reduced recovery time and fewer complications, are fueling market expansion. The rising geriatric population, who are more susceptible to cancer and other conditions treatable with cryoablation, further propels demand. Moreover, the increasing investment in healthcare infrastructure and research activities aimed at improving cryoablation techniques contributes to the market's upward trajectory. Overall, these factors collectively drive the adoption of cryoablation probes, positioning the market for continued growth in the coming years.

U.S. Cryoablation Probes Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cryoablation probes market report based on application and end use:

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Cardiac Arrhythmias
  • Oncology
    • Lung cancer
    • Prostate cancer
    • Breast cancer
    • Kidney cancer
    • Liver cancer
    • Others
  • Dermatology
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Cryoablation Probes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. U.S. Cryoablation Probes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Cryoablation Probes Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Cryoablation Probes Market Movement Analysis
  • 4.3. U.S. Cryoablation Probes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Cardiac Arrhythmias
    • 4.4.1. Cardiac arrhythmias market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. Oncology
    • 4.5.1. Oncology market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.1. Lung Cancer
        • 4.5.1.1.1. Lung cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.2. Prostate Cancer
        • 4.5.1.2.1. Prostate cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.3. Breast Cancer
        • 4.5.1.3.1. Breast cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.4. Kidney Cancer
        • 4.5.1.4.1. Kidney cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.5. Liver Cancer
        • 4.5.1.5.1. Liver cancer market estimates and forecast 2021 to 2033 (USD Million)
      • 4.5.1.6. Others
        • 4.5.1.6.1. Lung cancer market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Dermatology
    • 4.6.1. Dermatology market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Cryoablation Probes Devices: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Cryoablation Probes Market Movement Analysis
  • 5.3. U.S. Cryoablation Probes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty Clinics market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Ambulatory Surgery Centers (ASCs)
    • 5.6.1. Ambulatory Surgery Centers (ASCs) market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Atricure, Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Varian, A Siemens Healthineers Company
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. IceCure Medical
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Medtronic
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Bruker
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Erbe USA, Incorporated
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Keeler
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. HealthTronics, Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
  • 6.3. Company Market Share Analysis, 2024
  • 6.4. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. cryoablation probes market, by application, 2021 - 2033 USD Million
  • Table 4 U.S. cryoablation probes market, by end use, 2021 - 2033 USD Million

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Cryoablation Probes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Cryoablation Probes Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Cryoablation Probes Market, for Cardiac Arrhythmias, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Cryoablation Probes Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Cryoablation Probes Market, for Dermatology, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Cryoablation Probes Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Cryoablation Probes Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Cryoablation Probes Market, for Hospitals, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Cryoablation Probes Market, for Specialty Clinics, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Cryoablation Probes Market, for Ambulatory Surgery Centers (ASCs), 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Cryoablation Probes Market, for Others, 2021 - 2033 (USD Million)